Duloxetine for the treatment of major depressive disorder : A closer look at efficacy and safety data across the approved dose rangeMALLINCKRODT, Craig H; PRAKASH, Apurva; ANDORN, Anne C et al.Journal of psychiatric research. 2006, Vol 40, Num 4, pp 337-348, issn 0022-3956, 12 p.Article

Clinical consequences of initial duloxetine dosing strategies : Comparison of 30 and 60 mg QD starting dosesDUNNER, David L; WOHLREICH, Madelaine M; MALLINCKRODT, Craig H et al.Current therapeutic research. 2005, Vol 66, Num 6, pp 522-540, issn 0011-393X, 19 p.Article

The effect of duloxetine on painful physical symptoms in depressed patients: Do improvements in these symptoms result in higher remission rates?FAVA, Maurizio; MALLINCKRODT, Craig H; DETKE, Michael J et al.The Journal of clinical psychiatry. 2004, Vol 65, Num 4, pp 521-530, issn 0160-6689, 10 p.Article

Original article Comparison of safety outcomes among Caucasian, Hispanic, Black, and Asian patients in duloxetine studies of chronic painful conditionsGAYNOR, Paula J; PENG LIU; WELLER, Mary A et al.Current medical research and opinion. 2013, Vol 29, Num 5, pp 549-560, issn 0300-7995, 12 p.Article

Comparisons of the Efficacy and Safety of Duloxetine for the Treatment of Fibromyalgia in Patients With Versus Without Major Depressive DisorderARNOLD, Lesley M; HUDSON, James I; FUJUN WANG et al.The Clinical journal of pain. 2009, Vol 25, Num 6, pp 461-468, issn 0749-8047, 8 p.Article

Duloxetine in the treatment of major depressive disorder : Comparisons of safety and tolerability in male and female patientsSTEWART, Donna E; WOHLREICH, Madelaine M; MALLINCKRODT, Craig H et al.Journal of affective disorders. 2006, Vol 94, Num 1-3, pp 183-189, issn 0165-0327, 7 p.Article

Duloxetine for the Treatment of Recurrent Major Depressive Disorder in Elderly Patients: Treatment Outcomes in Patients With Comorbid ArthritisWOHLREICH, Madelaine M; SULLIVAN, Mark D; MALLINCKRODT, Craig H et al.Psychosomatics (Washington, DC). 2009, Vol 50, Num 4, pp 402-412, issn 0033-3182, 11 p.Article

Duloxetine in the treatment of major depressive disorder : Comparisons of safety and efficacyBAILEY, Rahn K; MALLINCKRODT, Craig H; WOHLREICH, Madelaine M et al.Journal of the National Medical Association. 2006, Vol 98, Num 3, pp 437-447, issn 0027-9684, 11 p.Article

Duloxetine in the treatment of major depressive disorder : Comparisons of safety and efficacy in U.S. Hispanic and majority caucasian patientsLEWIS-FERNANDEZ, Roberto; BLANCO, Carlos; MALLINCKRODT, Craig H et al.The Journal of clinical psychiatry. 2006, Vol 67, Num 9, pp 1379-1390, issn 0160-6689, 12 p.Article

Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorderBRANNAN, Stephen K; MALLINCKRODT, Craig H; BROWN, Eileen B et al.Journal of psychiatric research. 2005, Vol 39, Num 1, pp 43-53, issn 0022-3956, 11 p.Article

Duloxetine for the treatment of major depressive disorder in women ages 40 to 55 yearsBURT, Vivien K; WOHLREICH, Madelaine M; MALLINCKRODT, Craig H et al.Psychosomatics (Washington, DC). 2005, Vol 46, Num 4, pp 345-354, issn 0033-3182, 10 p.Article

The Cost-Effectiveness of Duloxetine in Chronic Low Back Pain: A US Private Payer PerspectiveWIELAGE, Ronald C; BANSAL, Megha; SCOTT ANDREWS, J et al.Value in health. 2013, Vol 16, Num 2, pp 334-344, issn 1098-3015, 11 p.Article

Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: Secondary analyses of four pooled randomized controlled trials of duloxetineMARANGELL, Lauren B; CLAUW, Daniel J; CHOY, Ernest et al.Pain (Amsterdam). 2011, Vol 152, Num 1, pp 31-37, issn 0304-3959, 7 p.Article

Pain Response Profile of Patients With Fibromyalgia Treated With DuloxetineBRADLEY, Laurence A; WOHLREICH, Madelaine M; FUJUN WANG et al.The Clinical journal of pain. 2010, Vol 26, Num 6, pp 498-504, issn 0749-8047, 7 p.Article

Flexible Dosed Duloxetine in the Treatment of Fibromyalgia: A Randomized, Double-blind, Placebo-controlled TrialARNOLD, Lesley M; CLAUW, Daniel; WANG, Fujun et al.Journal of rheumatology. 2010, Vol 37, Num 12, pp 2578-2586, issn 0315-162X, 9 p.Article

Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depressionSHELTON, Richard C; ANDORN, Anne C; MALLINCKRODT, Craig H et al.International clinical psychopharmacology. 2007, Vol 22, Num 6, pp 348-355, issn 0268-1315, 8 p.Article

An open-label study of duloxetine for the treatment of major depressive disorder : Comparison of switching versus initiating treatment approachesWOHLREICH, Madelaine M; MARTINEZ, James M; MALLINCKRODT, Craig H et al.Journal of clinical psychopharmacology. 2005, Vol 25, Num 6, pp 552-560, issn 0271-0749, 9 p.Article

Onset of Response with Duloxetine Treatment in Patients with Osteoarthritis Knee Pain and Chronic Low Back Pain: A Post Hoc Analysis of Placebo-Controlled TrialsWILLIAMSON, Owen D; SCHROER, Melissa; RUFF, Dustin D et al.Clinical therapeutics. 2014, Vol 36, Num 4, pp 544-551, issn 0149-2918, 8 p.Article

Duloxetine efficacy for major depressive disorder in male vs. female patients : Data from 7 randomized, double-blind, placebo-controlled trialsKORNSTEIN, Susan G; WOHLREICH, Madelaine M; MALLINCKRODT, Craig H et al.The Journal of clinical psychiatry. 2006, Vol 67, Num 5, pp 761-770, issn 0160-6689, 10 p.Article

What Makes Patients with Fibromyalgia Feel Better? Correlations Between Patient Global Impression of Improvement and Changes in Clinical Symptoms and Function: A Pooled Analysis of 4 Randomized Placebo-controlled Trials of DuloxetineHUDSON, James I; ARNOLD, Lesley M; BRADLEY, Laurence A et al.Journal of rheumatology. 2009, Vol 36, Num 11, pp 2517-2522, issn 0315-162X, 6 p.Article

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder : Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trialRUSSELL, I. Jon; MEASE, Philip J; SMITH, Timothy R et al.Pain (Amsterdam). 2008, Vol 136, Num 3, pp 432-444, issn 0304-3959, 13 p.Article

Long-Term Safety, Tolerability, and Efficacy of Duloxetine in the Treatment of FibromyalgiaMEASE, Philip J; RUSSELL, I. Jon; KAJDASZ, Daniel K et al.Seminars in arthritis and rheumatism. 2010, Vol 39, Num 6, pp 454-464, issn 0049-0172, 11 p.Article

A Randomized, Double-Blind Study of Increasing or Maintaining Duloxetine Dose in Patients Without Remission of Major Depressive Disorder After Initial Duloxetine TherapyKORNSTEIN, Susan G; DUNNER, David L; MEYERS, Adam L et al.The Journal of clinical psychiatry. 2008, Vol 69, Num 9, pp 1383-1392, issn 0160-6689, 10 p.Article

A Comparison of Initial Duloxetine Dosing Strategies in Patients With Major Depressive DisorderWHITMYER, Virgil G; DUNNER, David L; KORNSTEIN, Susan G et al.The Journal of clinical psychiatry. 2007, Vol 68, Num 12, pp 1921-1930, issn 0160-6689, 10 p.Article